Federal Supply Schedule V797D30226
- The Veterans Integrated Service Network 12 issued a Federal Supply Schedule contract to Sandoz Inc. on the Pharmaceuticals and Drugs (FSS-61-IB) schedule on August 15, 2023, with a contract ceiling of $683.2 million and final completion date of August 14, 2028. The contract is approved under Federal Supply Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products, and carries no set-aside designation. This is a multiple-award schedule vehicle, meaning agencies place orders...
- The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Dendreon Pharmaceuticals LLC under the Pharmaceuticals and Drugs (FSS-61-IB) schedule effective June 1, 2020, with performance continuing through December 31, 2026. The contract is a multiple-award vehicle with no set-aside designation and carries a ceiling value of $6,469,689. The contractor is approved to supply drugs, pharmaceuticals, and hematology-related products across the VA's integrated service networks....
- The Department of Veterans Affairs awarded a Federal Supply Schedule (FSS) contract to Hospira Worldwide LLC, a subsidiary of Pfizer Inc., for a wide range of pharmaceutical and medical products under the FSS-61 IB schedule. The $230 million multiple-award contract has a period of performance running from October 1, 2014 through June 30, 2024. Through this FSS contract, Hospira/Pfizer has provided sterile injectable drugs, antibiotics, anesthetics, IV solutions, and other medical supplies to...
- The federal contract IDV is a single-award Indefinite Delivery Contract (IDC) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, valued at a ceiling of $26,399,360.75, is for the supply of pegfilgrastim injectables to the VA, Bureau of Prisons, and Indian Health Service. The contract has a base period of one year and four one-year option periods, with an estimated annual...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Noven Therapeutics LLC on the Pharmaceuticals and Drugs (FSS-61-IB) schedule on October 15, 2020, with a ceiling value of $31,335,540. The contract is structured as a multiple-award vehicle under GSA Schedule 65 I B, covering drugs, pharmaceuticals, and hematology-related products. No set-aside category was applied. Place of performance is nationwide through the VA's supply ordering processes. The contract term...
- The Veterans Affairs awarded a Federal Supply Schedule contract to Sumitomo Pharma America, Inc. on September 1, 2026, under VA Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The contract carries a ceiling value of $2,895,337,960 and runs through August 31, 2031. As a multiple-award schedule vehicle, this contract enables VA and other federal agencies to place orders directly against the contractor's price list without conducting individual competitions. The...
- The Department of Veterans Affairs issued a Federal Supply Schedule contract to Scilex Pharmaceuticals Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on March 1, 2019, with a contract ceiling of $300,000.00 and ultimate completion date of August 1, 2027. The contract covers Special Item Number 65 I B, drugs, pharmaceuticals, and hematology-related products, and represents a contract extension under the multiple-award schedule vehicle. The Department of Veterans Affairs, Veterans...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a Federal Supply Schedule contract to Endo Usa, Inc. under the Pharmaceuticals and Drugs schedule (FSS-61-IB) on September 29, 2020, with a contract ceiling of $1,609,742,173.50 and ultimate completion date of September 30, 2027. This is a multiple-award vehicle enabling VA to purchase drugs, pharmaceuticals, and hematology-related products from an approved price list rather than through individual...
- The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024. The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D30226Federal Supply Schedule
- Blanket Purchase Agreements
- 50Federal Contract Awards
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications, and injectables. The IDV utilizes the VA's prime vendor program to distribute products to VA medical centers and other government healthcare facilities. It was awarded on an unrestricted basis with no set-asides and has a base year plus four one-year options. Associated task orders and blanket purchase agreements (BPAs) have been issued for specific drug products such as furosemide and alprazolam, valued at $7,228.71 and $5.1 million/$1.4 million respectively. This contract supports the medication needs of veterans, active duty military, federal inmates, and Native American populations served by the VA, DoD, and related government healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00371 | Other Administrative Action | $0 | 7/20/23 | |
| P00370 | Supplemental Agreement for work within scope | $0 | 6/13/23 | |
| P00369 | Supplemental Agreement for work within scope | $0 | 5/23/23 | |
| P00368 | Supplemental Agreement for work within scope | $0 | 3/22/23 | |
| P00367 | Supplemental Agreement for work within scope | $0 | 1/17/23 |
Name | Description | Awardee | Potential Value | AwardDate | LastDateToOrder | Updated At |
|---|---|---|---|---|---|---|
V797D30226-VA797P13A0008 | Sandoz Inc. | $5.1m | 8/15/13 | 6/30/16 | 5/5/15 | |
V797D30226-VA797P13A0009 | Sandoz Inc. | $1.4m | 8/15/13 | 3/14/16 | 8/13/13 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call VA797P13A0009-VA797P14J0082 | Sandoz Inc. | $44.9k | 9/16/14 | 9/30/14 | 9/16/14 | |
BPA Call VA797P13A0008-VA797P16J0006 | Sandoz Inc. | $15.0k | 10/26/15 | 10/26/15 | 10/26/15 | |
BPA Call VA797P13A0009-VA797P15J0014 | Sandoz Inc. | $44.8k | 12/3/14 | 12/17/14 | 12/3/14 | |
BPA Call VA797P13A0008-VA797P14J0078 | Sandoz Inc. | $65.4k | 9/16/14 | 9/30/14 | 9/16/14 | |
Delivery Order V797D30226-VA24714F2655 | Sandoz Inc. | $7.2k | 7/17/14 | 8/15/14 | 7/17/14 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
New contract award ICO Amphastar Pharmaceuticals | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 2/10/11, 3:09 PM |